Johnson & Johnson’s vaccine offers strong protection but fuels concern about variants

Michelle Dryden January 29, 2021Comments Off

The Johnson & Johnson’s vaccine’s efficacy rate dropped from 72 percent in the United States to just 57 percent in South Africa, where a highly contagious variant is driving most cases.

— NYT: Top Stories

Michelle Dryden (Author)

Michelle Dryden has come full-circle back to the exciting world of Journalism, news, and media. Dryden is an Independent Multimedia Journalist. She graduated with honors from Full Sail University. Dryden received the Advanced Achievement Award from Full Sail University's New Media Journalism Master's degree program, in June 2013. With journalism experiences in both digital and traditional journalism since 1996, she is a news veteran. The Media Pub News blog publishes core news and community features. What's your story? Email me at mdryden@themediapub.com. Cheers!!!

Share this:

Related Posts

Michelle Dryden (Author)